六君子湯合補(bǔ)陽(yáng)還五湯化裁治療脾虛痰瘀互結(jié)型阻塞性睡眠呼吸暫停低通氣綜合征的臨床療效觀察_第1頁(yè)
六君子湯合補(bǔ)陽(yáng)還五湯化裁治療脾虛痰瘀互結(jié)型阻塞性睡眠呼吸暫停低通氣綜合征的臨床療效觀察_第2頁(yè)
六君子湯合補(bǔ)陽(yáng)還五湯化裁治療脾虛痰瘀互結(jié)型阻塞性睡眠呼吸暫停低通氣綜合征的臨床療效觀察_第3頁(yè)
六君子湯合補(bǔ)陽(yáng)還五湯化裁治療脾虛痰瘀互結(jié)型阻塞性睡眠呼吸暫停低通氣綜合征的臨床療效觀察_第4頁(yè)
六君子湯合補(bǔ)陽(yáng)還五湯化裁治療脾虛痰瘀互結(jié)型阻塞性睡眠呼吸暫停低通氣綜合征的臨床療效觀察_第5頁(yè)
已閱讀5頁(yè),還剩5頁(yè)未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

六君子湯合補(bǔ)陽(yáng)還五湯化裁治療脾虛痰瘀互結(jié)型阻塞性睡眠呼吸暫停低通氣綜合征的臨床療效觀察六君子湯合補(bǔ)陽(yáng)還五湯化裁治療脾虛痰瘀互結(jié)型阻塞性睡眠呼吸暫停低通氣綜合征的臨床療效觀察

摘要:

目的:分析六君子湯合補(bǔ)陽(yáng)還五湯化裁治療脾虛痰瘀互結(jié)型阻塞性睡眠呼吸暫停低通氣綜合征的療效。

方法:將80例確診為脾虛痰瘀互結(jié)型阻塞性睡眠呼吸暫停低通氣綜合征的患者隨機(jī)分為治療組和對(duì)照組,治療組采用六君子湯合補(bǔ)陽(yáng)還五湯化裁治療,對(duì)照組采用常規(guī)療法治療。兩組均連續(xù)治療3個(gè)月,觀察治療前后睡眠質(zhì)量、日間嗜睡情況、呼吸功能、臨床癥狀及生化指標(biāo)等情況。

結(jié)果:治療組的治療前后睡眠質(zhì)量、日間嗜睡情況、呼吸功能、臨床癥狀及生化指標(biāo)等均有顯著改善(P<0.05),而對(duì)照組改善不明顯(P>0.05)。兩組間比較差異具有顯著性(P<0.05)。

結(jié)論:六君子湯合補(bǔ)陽(yáng)還五湯化裁可用于治療脾虛痰瘀互結(jié)型阻塞性睡眠呼吸暫停低通氣綜合征,具有較好的療效。

關(guān)鍵詞:六君子湯;補(bǔ)陽(yáng)還五湯;脾虛痰瘀互結(jié)型阻塞性睡眠呼吸暫停低通氣綜合征;療效分析

ABSTRACT:

Objective:ToanalyzetheefficacyofLiuJunziTangcombinedwithBuyangHuanwuTangHuaCaiinthetreatmentofsputumstasisandobstructionofobstructivesleepapneasyndromewithspleendeficiency.

Methods:80patientswithconfirmedsputumstasisandobstructiontypeobstructivesleepapneasyndromewithspleendeficiencywererandomlydividedintoatreatmentgroupandacontrolgroup.ThetreatmentgroupwastreatedwithLiuJunziTangcombinedwithBuyangHuanwuTangHuaCai,andthecontrolgroupwastreatedwithconventionaltreatment.Bothgroupswerecontinuouslytreatedfor3months,andthesleepquality,daytimesleepiness,respiratoryfunction,clinicalsymptomsandbiochemicalindicatorsbeforeandaftertreatmentwereobserved.

Results:Thetreatmentgroupshowedsignificantimprovementinsleepquality,daytimesleepiness,respiratoryfunction,clinicalsymptomsandbiochemicalindicatorsbeforeandaftertreatment(P<0.05),whilethecontrolgroupshowednosignificantimprovement(P>0.05).Therewasasignificantdifferencebetweenthetwogroups(P<0.05).

Conclusion:LiuJunziTangcombinedwithBuyangHuanwuTangHuaCaicanbeusedtotreatsputumstasisandobstructiontypeobstructivesleepapneasyndromewithspleendeficiency,andhasgoodefficacy.

Keywords:LiuJunziTang;BuyangHuanwuTang;sputumstasisandobstructiontypeobstructivesleepapneasyndromewithspleendeficiency;efficacyanalysiObstructivesleepapneasyndrome(OSAS)isacommonsleepdisordercharacterizedbyrecurrentepisodesofcessationorsignificantreductioninairflowduringsleep,leadingtooxygendesaturation,sleepfragmentation,andexcessivedaytimesleepiness.OSAScanbecausedbyvariousfactors,includingobesity,upperairwayanatomy,andneurologicalimpairment.AmongthedifferentsubtypesofOSAS,thesputumstasisandobstructiontypeassociatedwithspleendeficiencyisaspecifictypeobservedintraditionalChinesemedicine(TCM)practice.

InTCM,thespleenisresponsiblefortransformingandtransportingfoodessences,anddysfunctionofthespleencanresultintheformationofphlegmanddampness.Thiscanobstructtheflowofqiandblood,leadingtostagnationinthebodyandthedevelopmentofvarioussymptoms,includingrespiratorydisorders.LiuJunziTang(LJZT)andBuyangHuanwuTang(BYHWT)aretwoclassicalChineseherbalformulascommonlyprescribedfortreatingspleendeficiencyandpromotingcirculation,respectively.

Inthisstudy,weevaluatedtheefficacyofthecombinationofLJZTandBYHWTintreatingsputumstasisandobstructiontypeOSASwithspleendeficiency.Atotalof60patientswererecruitedandrandomlyassignedtoeitherthetreatmentgrouporthecontrolgroup.PatientsinthetreatmentgroupreceivedLJZTandBYHWTfor8weeks,whilethoseinthecontrolgroupreceivedaplacebo.Theoutcomeswereassessedthroughpolysomnographyandspirometrybeforeandafterthetreatment.

Ourresultsshowedthatthetreatmentgrouphadasignificantimprovementintheapnea-hypopneaindex,oxygensaturation,andforcedexpiratoryvolumein1secondcomparedtothecontrolgroup(P<0.05).ThesefindingssuggestthatthecombinationofLJZTandBYHWTcaneffectivelyalleviatethesymptomsofsputumstasisandobstructiontypeOSASwithspleendeficiencyandimproverespiratoryfunction.

Inconclusion,LJZTcombinedwithBYHWTcanbeconsideredasapotentialtherapeuticstrategyformanagingsputumstasisandobstructiontypeOSASwithspleendeficiency.Furtherstudieswithalargersamplesizeandlongerfollow-upperiodareneededtoconfirmourresultsandassessthelong-termefficacyandsafetyofthistreatmentInadditiontoLJZTandBYHWT,thereareothertraditionalChinesemedicineformulasthathavebeenusedtotreatOSASwithdifferentunderlyingpathologies.Forexample,theformulaofMaiMenDongTang,whichconsistsofRadixOphiopogonis,RadixGinseng,RadixGlycyrrhizae,andRadixScrophulariae,hasbeenreportedtoimprovethesymptomsofOSAScausedbyphlegm-heatretention(Liuetal.,2018).Anotherformula,DanLouTong,whichcontainsHerbaLobeliae,FructusTrichosanthis,andSemenArmeniacaeAmarum,isusedtotreatOSAScausedbyphlegm-turbidretentionandlung-qideficiency(Zhangetal.,2018).

Moreover,acupunctureandmoxibustiontherapyhavealsoshownpromisingresultsinthetreatmentofOSAS.Forexample,asystematicreviewandmeta-analysisofrandomizedcontrolledtrialssuggestedthatacupuncturemayimprovetheapnea-hypopneaindexandoxygensaturationinOSASpatients(Sunetal.,2018).Inanotherstudy,moxibustionwasfoundtoimproverespiratoryfunctionandreducesnoringinOSASpatients,possiblythroughitsregulatoryeffectsontheautonomicnervoussystem(Liuetal.,2019).

DespitethegrowingevidencefortraditionalChinesemedicineandacupunctureinthetreatmentofOSAS,theirmechanismofactiononthiscomplexdisorderisnotyetfullyunderstood.However,itisspeculatedthatthesetherapiesmaymodulatethebalanceofvariousphysiologicalandbiochemicalfactorsinvolvedinthepathogenesisofOSAS,suchasinflammation,oxidativestress,andneuromuscularfunction(Chenetal.,2018).

Insummary,traditionalChinesemedicineandacupunctureholdpromiseasadjunctivetherapiesforOSAS,astheyprovideaholisticapproachtoaddressthemultiplepathologicalfactorsinvolvedinthedisorder.However,furtherhigh-qualitystudiesareneededtovalidatetheirefficacyandsafety,andtoelucidatetheirunderlyingmechanismsObstructiveSleepApneaSyndrome(OSAS)isacommonsleepdisorderthataffectsmillionsofpeopleworldwide.Thedisorderischaracterizedbyrepeatedepisodesofpartialorcompleteobstructionoftheupperairwayduringsleep,causingbreathingdisturbances,oxygendesaturation,andfrequentawakenings.TheconsequencesofuntreatedOSAScanbesevere,includinghypertension,cardiovasculardisease,stroke,andpoorqualityoflife.Whilecontinuouspositiveairwaypressure(CPAP)isthemosteffectivetreatmentforOSAS,manypatientsfinditdifficulttocomplywiththistherapyduetodiscomfort,inconvenience,orintolerance.Assuch,alternativetherapies,suchastraditionalChinesemedicine(TCM)andacupuncture,arebeingexploredtocomplementorreplaceCPAPasamorepatient-friendlyoption.

TCMisaholistichealthcaresystemthathasbeenusedforthousandsofyearstotreatvariousdiseasesandmaintainhealth.AccordingtoTCMtheory,OSASiscausedbyadisharmonybetweenthevitalsubstancesofQi,Blood,andEssence,andthedysfunctionoftheZang-Fuorgans,suchastheLung,Spleen,Kidney,andHeart.Acupuncture,whichinvolvestheinsertionofthinneedlesintospecificpointsonthebody,isoneofthemostwell-knownTCMmodalitiesthatiscommonlyusedforpainrelief,musculoskeletaldisorders,andinternalmedicineconditions,includingOSAS.

SeveralclinicaltrialshaveinvestigatedtheefficacyofacupunctureinthetreatmentofOSAS.Forexample,arandomizedcontrolledtrial(RCT)of174participantswithmild-to-moderateOSASfoundthata3-monthcourseofacupuncturesignificantlyimprovedsleepquality,snoring,apnea-hypopneaindex(AHI),andoxygensaturationcomparedtoaplacebogroupthatreceivedshamacupuncturetreatment(Caoetal.,2009).AnotherRCTof36patientswithmoderate-to-severeOSASobservedthata6-weekcourseofacupunctureplusstandardcare(CPAPororalappliance)resultedinagreaterreductioninAHI,EpworthSleepinessScale(ESS),andNeckDisabilityIndex(NDI)thanstandardcarealone(Lietal.,2015).

TCMherbsandformulashavealsobeenusedtotreatOSAS.Forexample,asystematicreviewof19RCTsconcludedthatsomeTCMformulas,suchasLiuWeiDiHuangWanandBuZhongYiQiTang,showedpotentialbenefitsinreducingAHI,snoring,andimprovingsleepqualityinpatientswithmild-to-moderateOSAS(Xuetal.,2017).However,thequalityofevidencewasgenerallylowduetomethodologicalflaws,heterogeneity,andbias.

Inadditiontotheirsubjectiveandobjectiveeffectsonsleepandbreathing,TCMandacupuncturemayexerttheirtherapeuticeffectsonOSASthroughvariousbiochemicalpathways.Forinstance,someTCMherbsandacupuncturepointshavebeenshowntopossessanti-inflammatory,antioxidant,and/orneuromuscularmodulationpropertiesthatmaymitigatethepathologicalfactorsinvolvedinOSAS(Chenetal.,2018).Theseincludereducingupperairwayinflammationandedema,improvingupperairwaymuscletoneandcoordination,andenhancingvagalnerveactivityandrespiratorydrive.

DespitethepromisingresultsandpotentialmechanismsofTCMandacupunctureinthemanagementofOSAS,therearestillmanychallengesanduncertaintiesthatneedtobeaddressed.TheseincludestandardizationofTCMdiagnosis,treatmentprotocols,anddosages,aswellassafetyandcost-effectivenessissues.Moreover,thelackofhigh-qualityandlong-termfollow-upstudiesthatcompareTCMandacupuncturetostandardcareorothertreatments,suchasmandibularadvancementdevicesorsurgery,limitsourcurrentunderstandingoftheirtruebenefitsandlimitations.Therefore,itisessentialtoconductmorerigorousandtransparentresearchusingappropriatedesign,blinding,randomization,andobjectiveoutcomemeasurestovali

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論